|
1
|
Kwong DL, Sham JS, Leung LH, Cheng AC, Ng
WM, Kwong PW, Lui WM, Yau CC, Wu PM, Wei W and Au G: Preliminary
results of radiation dose escalation for locally advanced
nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 64:374–381.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng AQ, Song XR, Yu JM, Wei L and Wang
XW: Liposome transfected to plasmid-encoding endostatin gene
combined with radiotherapy inhibits liver cancer growth in nude
mice. World J Gastroenterol. 11:4439–4442. 2005.PubMed/NCBI
|
|
3
|
Harari PM and Huang SM: Head and neck
cancer as a clinical model for molecular targeting of therapy:
combining EGFR blockade with radiation. Int J Radiat Oncol Biol
Phys. 49:427–433. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weichselbaum RR and Kufe D: Translation of
the radio- and chemo-inducible TNFerade vector to the treatment of
human cancers. Cancer Gene Ther. 16:609–619. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kufe D and Weichselbaum R: Radiation
therapy: activation for gene transcription and the development of
genetic radiotherapy-therapeutic strategies in oncology. Cancer
Biol Ther. 2:326–329. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond
HP and Wang JH: Combined IFN-gamma-endostatin gene therapy and
radiotherapy attenuates primary breast tumor growth and lung
metastases via enhanced CTL and NK cell activation and attenuated
tumor angiogenesis in a murine model. Ann Surg Oncol. 16:1403–1411.
2009. View Article : Google Scholar
|
|
7
|
Yang W and Li XY: Anti-tumor effect of
pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing
Lewis lung carcinoma and its mechanism. Chin Med J (Engl).
118:296–301. 2005.PubMed/NCBI
|
|
8
|
Li Y, Guo C, Wang Z, Gong P, Sun Z and
Gong S: Enhanced effects of TRAIL-endostatin-based
double-gene-radiotherapy on suppressing growth, promoting apoptosis
and inducing cell cycle arrest in vascular endothelial cells. J
Huazhong Univ Sci Technolog Med Sci. 32:167–172. 2012. View Article : Google Scholar
|
|
9
|
Toma-Daşu I, Daşu A and Karlsson M: The
relationship between temporal variation of hypoxia, polarographic
measurements and predictions of tumor response to radiation. Phys
Med Biol. 49:4463–4475. 2004.PubMed/NCBI
|
|
10
|
Lok CN and Ponka P: Identification of a
hypoxia response element in the transferrin receptor gene. J Biol
Chem. 274:24147–24152. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okino ST, Chichester CH and Whitlock JP
Jr: Hypoxia-inducible mammalian gene expression analyzed in vivo at
a TATA-driven promoter and at an initiator-driven promoter. J Biol
Chem. 273:23837–23843. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kwon OJ, Kim PH, Huyn S, Wu L, Kim M and
Yun CO: A hypoxia-and {alpha}-fetoprotein-dependent oncolytic
adenovirus exhibits specific killing of hepatocellular carcinomas.
Clin Cancer Res. 16:6071–6082. 2010. View Article : Google Scholar
|
|
13
|
Leskov KS, Criswell T, Antonio S, Li J,
Yang CR, Kinsella TJ and Boothman DA: When X-ray-inducible proteins
meet DNA double strand break repair. Semin Radiat Oncol.
11:352–372. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX
and Cao ZH: HSV-TK gene therapy of lung adenocarcinoma xenografts
using a hypoxia/radiation dual-sensitive promoter. Ai Zheng.
23:788–793. 2004.(In Chinese).
|
|
15
|
Wu G, Chai J, Suber TL, Wu JW, Du C, Wang
X and Shi Y: Structural basis of IAP recognition by Smac/DIABLO.
Nature. 408:1008–1012. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mühlethaler-Mottet A, Bourloud KB,
Auderset K, Joseph JM and Gross N: Drug-mediated sensitization to
TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma
cells proceeds via activation of intrinsic and extrinsic pathways
and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Oncogene.
23:5415–5425. 2004.
|
|
17
|
McNeish IA, Bell S, McKay T, Tenev T,
Marani M and Lemoine NR: Expression of Smac/DABLO in ovarian
carcinoma cells induces apoptosis via a caspase-9 mediated pathway.
Exp Cell Res. 286:186–198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du N, Yang B, Hu LJ, Zhao Y, Sun X, Guo ZW
and Ren H: Overexpression of Smac gene enhanced chemotherapeutic
sensitivity of esophageal cancer cell line Eca109 to cisplatin. Xi
Bao Yu Fen Zi Mian Yi Xue Za Zhi. 28:344–346. 2012.(In
Chinese).
|
|
19
|
Guo C, Li Y, Zhang H, et al: Enhancement
of antiproliferative and proapoptotic effects of cadmium chloride
combined with hSmac in hepatocellular carcinoma cells.
Chemotherapy. 57:27–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai M, Cui P, Yu M, Han J, Li H and Xiu R:
Melatonin modulates the expression of VEGF and HIF-1 alpha induced
by CoCl2 in cultured cancer cells. J Pineal Res.
44:121–126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu G, Gong P, Zhao H, Wang Z, Gong S and
Cai L: Effect of low-level radiation on the death of male germ
cells. Radiat Res. 165:379–389. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
United Nations Scientific Committee on the
Effects of Atomic Radiation: 1986 Report to the General Assembly,
with annexes. In: General Assembly Official Records: Forty-first
session, Supplement No. 16 (A/41/16); United Nations; New York, NY:
1986
|
|
23
|
Koressaar T and Remm M: Enhancements and
modifications of primer design program Primer3. Bioinformatics.
23:1289–1291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harada H: How can we overcome tumor
hypoxia in radiation therapy? J Radiat Res. 52:545–556. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Min FL, Zhang H and Li WJ: Current status
of tumor radiogenic therapy. World J Gastroenterol. 11:3014–3019.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mizutani Y, Nakanishi H, Yamamoto K, Li
YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B and
Miki T: Downregulation of Smac/DIABLO expression in renal cell
carcinoma and its prognostic significance. J Clin Oncol.
23:448–454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pluta P, Cebula-Obrzut B, Ehemann V, et
al: Correlation of Smac/DIABLO protein expression with the
clinico-pathological features of breast cancer patients. Neoplasma.
58:430–435. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fulda S, Wick W, Weller M and Debatin KM:
Smac agonists sensitize for Apo-2L/TRAIL or anticancer drug-induced
apoptosis and induce regression of malignant glioma in vivo. Nat
Med. 8:808–815. 2002.PubMed/NCBI
|
|
29
|
Fulda S and Vucic D: Targeting IAP
proteins for therapeutic intervention in cancer. Nat Rev Drug
Discov. 11:109–124. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Le Bras M, Rouy I and Brenner C: The
modulation of inter-organelle cross-talk to control apoptosis. Med
Chem. 2:1–12. 2006.PubMed/NCBI
|
|
31
|
Flanagan L, Sebastià J, Tuffy LP, Spring
A, Lichawska A, Devocelle M, Prehn JH and Rehm M: XIAP impairs Smac
release from the mitochondria during apoptosis. Cell Death Dis.
1:e492010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou LL, Zhou LY, Luo KQ and Chang DC:
Smac/DIABLO and cytochrome c are released from mitochondria
through a similar mechanism during UV-induced apoptosis. Apoptosis.
10:289–99. 2005.PubMed/NCBI
|
|
33
|
Zeng HL, Zhong Q, Qin YL, Bu QQ, Han XA,
Jia HT and Liu HW: Hypoxia-mimetic agents inhibit proliferation and
alter the morphology of human umbilical cord-derived mesenchymal
stem cells. BMC Cell Biol. 12:322011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang SM and Harari PM: Modulation of
radiation response after epidermal growth factor receptor blockade
in squamous cell carcinomas: inhibition of damage repair, cell
cycle kinetics, and tumor angiogenesis. Clin Cancer Res.
6:2166–2174. 2000.
|
